Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > THE SCIENCE

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Nov 27, 2020 11:32am

112 Views

Post# 31989189

RE:RE:RE:THE SCIENCE

Let's not forget TRIL dropped from over $7 to $.48, with no negative results, but a major selldown going into a financing at $0.80 at a time when the stock was trading at about $1.65. That was for 26MM out then add a few splits Aswell as 6 of the 7 directors did not own a single share. Honestly makes Sernova look pretty damn good. Some people on this board would be having an a aneurism if they held TRIL in 2019. So let's keep things in perspective.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China